bioRxivBiochemistry
Design Principles for Inflammasome Inhibition by Pyrin-Only-Proteins
Z. Mazanek, S. Wu, G. Belotte, J. J. Zhou, C. M. Stallings, A. Garg, J. Lueck, J. Sohn
Abstract
Inflammasomes are filamentous signaling platforms essential for host defense against various intracellular calamities such as pathogen invasion and genotoxic stresses. However, dysregulated inflammasomes cause an array of human diseases including autoinflammatory disorders and cancer. It was recently identified that endogenous pyrin-only-proteins (POPs) regulate inflammasomes by directly inhibiting their filament assembly. Here, by combining Rosetta in silico, in vitro, and in cellulo methods, we investigate the target specificity and inhibition mechanisms of POPs. In contrast to a previous report, we find that POP1 is a poor inhibitor of the central inflammasome adaptor ASC. Instead, POP1 inhibits the assembly of upstream receptor PYD filaments such as those of AIM2, IFI16, NLRP3, and NLRP6. Moreover, not only does POP2 directly suppress the nucleation of ASC, but it can also inhibit the elongation of receptor filaments. In addition to inhibiting the elongation of AIM2 and NLRP6 filaments, POP3 potently suppresses the nucleation of ASC. Our Rosetta analyses and biochemical experiments consistently suggest that a combination of favorable and unfavorable interactions between POPs and PYDs is necessary for effective recognition and inhibition. Together, we reveal the intrinsic target redundancy of POPs and their inhibitory mechanisms.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Directionality of PYD filament growth determined by the transition of NLRP3 nucleation seeds to ASC elongation
I. V. Hochheiser, H. Behrmann, … M. Geyer·bioRxiv·Nov 25, 2021
- Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation
J. D. Rosarda, C. R. Stanton, … L. Wiseman·bioRxiv·Aug 21, 2023
- An optogenetic approach to control and monitor inflammasome activation.
J. Nadjar, S. Monnier, … V. Petrilli·bioRxiv·Jul 25, 2023
- Human caspase-1 autoproteolysis is required for ASC-dependent and -independent inflammasome activation
D. P. Ball, C. Y. Taabazuing, … D. A. Bachovchin·bioRxiv·Jun 24, 2019
- Structural basis for distinct inflammasome complex assembly by human NLRP1 and CARD8
Q. Gong, K. Robinson, … B. Reversade·bioRxiv·Jun 17, 2020
- DPP9 is an endogenous and direct inhibitor of the NLRP1 inflammasome that guards against human auto-inflammatory diseases
Franklin L. Zhong, Kim Robinson, … Bruno Reversade·bioRxiv·Feb 7, 2018